IGF2BP2 and breast cancer: Recently, an intriguing study reported that IGF2BP2 promoted the degradation of the RNA transcript encoding ATP6V1A, a catalytic subunit of the vacuolar ATPase, thus impairing lysosomal function and resulting in a unique secretome that greatly enhances breast cancer cell invasiveness 20.